Women make about 84 percent of the health decisions in the country when you account for their influence on their children, spouses or partners, parents and themselves. The nation needs to be more proactive about health instead of making it a topic of discussion when there's a disease outbreak or natural disaster, she said. Gerberding said she came to Syracuse because of her relationship with Walsh and her desire to promote health awareness on a local level. CDC expert endorses preventive...

But a new scheme to reintroduce the raptors - the world's fourth-biggest bird of prey - to the east coast has been so successful that they have taken to swooping over urban areas, causing awe, fear and alarm along the way. Until recently, anyone wanting to catch a glimpse of a sea eagle had to travel to the Hebrides and parts of Scotland's west coast, where the birds have gradually been reintroduced since the Seventies. One farmer has said that a sea eagle has been taking his poultry,...

One of the biggest domestic brands in the frozen fruits and. According to market circles the climate was fair enough to put pressure on the prices. An analysis of the market report shows that this has happened because of the lower price. Two copies of the applications and survey plan of. The trading activities were in a. This decision was taken at a meeting between the Kerala Minister for Food and Civil Supplies, Mr. While the coffee produced at its Thuthampara estate won the....

Subsequent investigations revealed that the diethylene glycol found in the cough syrup had a Chinese origin and that it had been passed off to a Spanish company as 99. At the end of a long and difficult global investigation, they discovered the source diethylene glycol-contaminated medicine used to treat fevers in small children. The modus operandi was also the same: bulk chemicals fraudulently identified as safe glycerin were sold to European companies, which then passed them on to drug...

Portland - PORTLAND -- AVI BioPharma, inc. (Nasdaq:AVII), today announced clinical development updates on AVI-4658, AVI s lead drug candidate for Duchenne muscular dystrophy (DMD) that is based on the company s proprietary ESPRIT (Exon Skipping Pre-RNA Interference Technology) drug platform. Portland - PORTLAND -- AVI BioPharma, inc. (Nasdaq:AVII), today announced clinical development updates on AVI-4658, AVI s lead drug candidate for Duchenne muscular dystrophy (DMD) that is based on the...